Skip to main
NEOG

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Neogen is viewed favorably because its turnaround is now showing tangible operating momentum, with several consecutive quarters of improving performance, accelerating Food Safety growth, and a more scalable commercial model focused on strategic accounts and integrated solutions. The company also appears better positioned financially, having generated $26.2 million of free cash flow in the fourth quarter, ended fiscal 2026 with positive free cash flow, and expecting leverage to move below 3x by the end of calendar 2026, supported by planned divestiture proceeds. In addition, restored product availability, improving adjusted EBITDA margins, and the progressing manufacturing transition through November 2026 reduce key execution risks and support a path toward more sustainable profitable growth.

Bears say

Neogen is facing a difficult fundamental setup because it has committed substantial capital to manufacturing Petrifilm while still finalizing the integration of 3M assets and personnel, a combination that can slow operations, disrupt production, and lift expenses. The larger debt load taken on to finance the 3M transaction has increased interest costs and reduced liquidity, leaving the company more vulnerable if top-line growth does not keep pace with the larger operating base. In addition, its food and animal safety businesses remain cyclical and exposed to inflation, food production volumes, supply-chain disruptions, and intense competition, which could pressure margins and delay a turnaround.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Oct 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.